CID 16078219
5-oxazolidinecarboxamide, n-[(1s,2r)-2-hydroxy-3-[[(3-fluoro-4-methoxyphenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)propyl]-2-oxo-3-(3-trifluoromethylphenyl)-, (5s)-
Structural Information
- Molecular Formula
- C32H35F4N3O7S
- SMILES
- CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)[C@@H]2CN(C(=O)O2)C3=CC=CC(=C3)C(F)(F)F)O)S(=O)(=O)C4=CC(=C(C=C4)OC)F
- InChI
- InChI=1S/C32H35F4N3O7S/c1-20(2)17-38(47(43,44)24-12-13-28(45-3)25(33)16-24)18-27(40)26(14-21-8-5-4-6-9-21)37-30(41)29-19-39(31(42)46-29)23-11-7-10-22(15-23)32(34,35)36/h4-13,15-16,20,26-27,29,40H,14,17-19H2,1-3H3,(H,37,41)/t26-,27+,29-/m0/s1
- InChIKey
- GOKNBQOQISRCDE-GKRYNVPLSA-N
- Compound name
- (5S)-N-[(2S,3R)-4-[(3-fluoro-4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-2-oxo-3-[3-(trifluoromethyl)phenyl]-1,3-oxazolidine-5-carboxamide
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 682.22048 | 252.9 |
[M+Na]+ | 704.20242 | 252.9 |
[M-H]- | 680.20592 | 258.6 |
[M+NH4]+ | 699.24702 | 249.6 |
[M+K]+ | 720.17636 | 251.6 |
[M+H-H2O]+ | 664.21046 | 240.0 |
[M+HCOO]- | 726.21140 | 256.4 |
[M+CH3COO]- | 740.22705 | 275.7 |
[M+Na-2H]- | 702.18787 | 247.4 |
[M]+ | 681.21265 | 253.8 |
[M]- | 681.21375 | 253.8 |